Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Pan AMPK Activation Protects Tubules in Rat Ischemic Acute Kidney Injury.

Autor: Frikke-Schmidt H; Cardiovascular Metabolism, Retina & Pulmonary Hypertension, Johnson & Johnson Innovative Medicine, United States HFrikkeS@ITS.JNJ.com., Albarazanji K; Cardiovascular Metabolism, Retina & Pulmonary Hypertension, Johnson & Johnson Innovative Medicine, United States., Qi J; Cardiovascular Metabolism, Retina & Pulmonary Hypertension, Johnson & Johnson Innovative Medicine, United States., Frederick D; Cardiovascular Metabolism, Retina & Pulmonary Hypertension, Johnson & Johnson Innovative Medicine, United States., Steffen J; Cardiovascular Metabolism, Retina & Pulmonary Hypertension, Johnson & Johnson Innovative Medicine, United States., Kalyana-Sundaram S; Cardiovascular Metabolism, Retina & Pulmonary Hypertension, Johnson & Johnson Innovative Medicine, United States., Meng R; Cardiovascular Metabolism, Retina & Pulmonary Hypertension, Johnson & Johnson Innovative Medicine, United States., Devine ZH; Cardiovascular Metabolism, Retina & Pulmonary Hypertension, Johnson & Johnson Innovative Medicine, United States., Chen T; Preclincial Sciences and Translational Safety, Johnson & Johnson Innovative Medicine, China., Li Q; Cardiovascular Metabolism, Retina & Pulmonary Hypertension, Johnson & Johnson Innovative Medicine, United States., Du F; Cardiovascular Metabolism, Retina & Pulmonary Hypertension, Johnson & Johnson Innovative Medicine, United States., Ho G; Cardiovascular Metabolism, Retina & Pulmonary Hypertension, Johnson & Johnson Innovative Medicine, United States., Liu J; Cardiovascular Metabolism, Retina & Pulmonary Hypertension, Johnson & Johnson Innovative Medicine, United States., Riley R; Non-Clinical Safety Pathology, Johnson & Johnson Innovative Medicine, United States., Gonzalez-Villalobos RA; Cardiovascular Metabolism, Retina & Pulmonary Hypertension, Johnson & Johnson Innovative Medicine, United States., Camacho RC; Cardiovascular Metabolism, Retina & Pulmonary Hypertension, Johnson & Johnson Innovative Medicine, United States., Nawrocki AR; Cardiovascular Metabolism, Retina & Pulmonary Hypertension, Johnson & Johnson Innovative Medicine, United States., Pryor M; Therapeutics Discovery, Johnson & Johnson Innovative Medicine, United States., Lee M; Therapeutics Discovery, Johnson & Johnson Innovative Medicine, United States., Wong V; Therapeutics Discovery, Johnson & Johnson Innovative Medicine, United States., Matico R; Therapeutics Discovery, Johnson & Johnson Innovative Medicine, United States., Diaz E; Therapeutics Discovery, Johnson & Johnson Innovative Medicine, United States., Krosky D; Therapeutics Discovery, Johnson & Johnson Innovative Medicine, United States., Wall M; Discovery Chemistry, Johnson & Johnson Innovative Medicine, United States., Gao E; Discovery Chemistry, Johnson & Johnson Innovative Medicine, United States., Shah AA; Discovery Chemistry, Johnson & Johnson Innovative Medicine, United States., Leonard J; Cardiovascular Metabolism, Retina & Pulmonary Hypertension, Johnson & Johnson Innovative Medicine, United States., Erion M; Cardiovascular Metabolism, Retina & Pulmonary Hypertension, Johnson & Johnson Innovative Medicine, United States., Pocai A; Cardiovascular Metabolism, Retina & Pulmonary Hypertension, Johnson & Johnson Innovative Medicine, United States., Player MR; Discovery Chemistry, Johnson & Johnson Innovative Medicine, United States.

Publikováno v: The Journal of pharmacology and experimental therapeutics [J Pharmacol Exp Ther] 2024 Jun 07. Date of Electronic Publication: 2024 Jun 07.